Funded Startups Agent

Deepansh Vashisth

← All reports

Saturday, 20 June 2026

Weekly Funded Startups Digest — 2026-06-20

Weekly Funded Startups Digest — 2026-06-20

Coverage window: Prior calendar week Mon 9 Jun – Sun 15 Jun 2026 (announcements with verified source links only).

Top 3 this week (Slack summary)

  1. Hoola Health (India) — $5M paediatric healthtech scaling 5→35 clinics; strongest overlap with your HealthPlix 0-to-1 + clinic workflow experience.
  2. Equal AI (India) — $30M Series B consumer AI super-app at 1M+ MAU; high-velocity growth PM role as they expand beyond call screening.
  3. Scispot (Canada) — $8M Series A healthtech/life-sciences SaaS with active Senior AI Product Designer/Manager role; remote listed as Ontario-only — cross-border from India unverified but worth outreach given healthtech fit.

India (10 companies)

1. Hoola Health

Funding: $5M (undisclosed stage; Surge-led growth round) — 10 Jun 2026
Source: https://yourstory.com/2026/06/hoola-health-5-million-funding-peak-xv-surge
What they do:

  • Bengaluru-based integrated paediatric healthcare platform (formerly BabyMD)
  • Neighbourhood clinics for consultations, vaccinations, diagnostics, therapy + parent-facing digital tools
  • Currently 5–6 clinics in Bengaluru; 20,000+ families served Why hiring now:
  • Capital earmarked for expansion to 35 centres across Bengaluru, Hyderabad, and Delhi-NCR over 24 months
  • Building digital stack for vaccination tracking, growth monitoring, and longitudinal health records Role hypothesis: Product Manager, Senior Product Manager (clinic ops + consumer app) Fit thesis: Direct healthtech + clinic workflow overlap with HealthPlix — you shipped specialty EMR 0-to-1, funnel instrumentation, and retention loops in a doctor-facing SaaS context. Paediatric clinic expansion is a classic PM problem: activation, repeat visits (~60% returning), and multi-city playbook replication. Proof points:
  • 0-to-1 gynecology EMR launch with measurable demo-to-activation uplift at HealthPlix
  • Refer-and-earn growth loop design (15% lead volume, 90% junk-lead reduction) Entry path:
  1. Check Peak XV/Surge portfolio jobs and LinkedIn for Hoola Health PM listings
  2. Identify founder Deeksha Senguttuvan on LinkedIn
  3. Outreach angle: clinic expansion playbook + parent-app retention from scaled healthtech Outreach draft:

Hi Deeksha — I saw Hoola’s $5M round and the 5→35 clinic expansion plan. I spent 6 years at HealthPlix (Series C healthtech), where I launched a specialty EMR 0-to-1 and built retention/growth loops across 10K+ doctors. I’d love to explore how you’re thinking about product as you scale clinics + the parent digital layer. Open to a 15-min chat?

Risk flags: No public PM job posting found this week; clinic-heavy ops may prioritize ops/clinical roles early.

2. Equal AI

Funding: $30M Series B — 12 Jun 2026
Source: https://techcrunch.com/2026/06/11/equal-ai-raises-30m-to-screen-calls-so-indians-dont-have-to/
What they do:

  • AI call assistant for spam screening and intent handling; expanding into everyday services (finance, shopping, concierge)
  • 1M+ MAU, 350K DAU in <8 months; founded by Keshav Reddy (prior enterprise identity/data infra) Why hiring now:
  • Series B to deepen call assistant, launch iOS, paid tier, and outbound calling features
  • Competing with Truecaller/Google; expanding from calls into super-app use cases Role hypothesis: Product Manager, Senior Product Manager (consumer growth / AI features) Fit thesis: Consumer-first product at scale with retention and activation challenges — your Mixpanel/SQL funnel work and growth loop design map directly. Psychology background helps for trust/UX in high-stakes communication products. Proof points:
  • Refer-and-earn and Google Review win-back (75% rate) — growth mechanics in consumer contexts
  • SceneDrop research (65% post-watch engagement gap) — user psychology + product discovery Entry path:
  1. Search LinkedIn jobs / Equal AI careers
  2. Identify founder Keshav Reddy or product leadership
  3. Angle: consumer activation/retention in India-first AI products Outreach draft:

Hi Keshav — congrats on the Series B. Equal AI’s 1M MAU in <8 months is impressive. I’m a PM (ex-HealthPlix) who combines qualitative research with funnel analytics — I’d love to discuss how you’re prioritizing the expansion from call screening into everyday services. Happy to share how we moved activation/retention at scale in healthtech.

Risk flags: Crowded category (Truecaller, Google); tranched round structure suggests milestone pressure.

3. 4baseCare

Funding: ~$4M (₹38 Cr) additional Series B close (total round ₹128 Cr / ~$13M) — 13 Jun 2026
Source: https://inc42.com/buzz/4basecare-bags-%E2%82%B938-cr-to-close-series-b-round-at-%E2%82%B9128-cr/
What they do:

  • Precision oncology / genomics startup with OncoTwin AI clinical decision support
  • Expanding hospital-linked genomics lab network across India, Middle East, SEA, LATAM Why hiring now:
  • Series B close to scale OncoTwin AI and global lab network
  • Focus on non-Caucasian genomic datasets — India-relevant data moat Role hypothesis: Product Manager (clinical AI / platform), Senior Product Manager Fit thesis: Healthtech SaaS + data-driven product decisions. Your HealthPlix experience with specialty workflows, clinician-facing tools, and investor-facing product narrative transfers to oncology decision-support — different clinical domain, same PM muscle. Proof points:
  • SQL/Mixpanel funnel analysis driving roadmap reprioritization (+8% active usage)
  • Investor walk-throughs with 15+ VCs during Series C Entry path:
  1. Check 4baseCare careers / LinkedIn
  2. Identify co-founder & CEO Hitesh Goswami
  3. Angle: clinician-facing AI product at scale in Indian health context Outreach draft:

Hi Hitesh — congrats on closing the Series B. I’m a PM with 6+ years in Indian healthtech (HealthPlix, Series C), where I shipped clinician-facing workflows and used SQL/Mixpanel to drive roadmap decisions. OncoTwin’s push on non-Caucasian genomic data is compelling — I’d welcome a conversation about product as you scale globally.

Risk flags: Deep clinical/regulatory domain; oncology genomics may prefer PMs with lifesciences background.

4. BazaarNow

Funding: ~$7.5M (₹72 Cr; round size varies by source) — 9 Jun 2026
Source: https://yourstory.com/2026/06/quick-commerce-startup-bazaarnow-raises-rs-72-cr-led-by-peak-xv-partners
What they do:

  • Quick commerce for Tier 2/3 cities; habit-led grocery + daily essentials
  • Founded by ex-Zepto/Swiggy/Myntra operators; launched Jan 2026; ~1,800 orders/day/store in early markets Why hiring now:
  • Expand to surrounding towns and regional clusters; deepen assortment and local-language UX
  • Peak XV-led round signals aggressive GTM scaling Role hypothesis: Product Manager (consumer app / growth), Senior Product Manager Fit thesis: Tier 2–3 user insight from your field sales background (20+ geographies, 1,000+ doctor onboardings) is a rare PM edge for non-metro quick commerce. Consumer growth + supply chain product problems match your profile. Proof points:
  • Tier 2–3 acquisition/conversion understanding from ASM role at HealthPlix
  • Growth loop design (refer-and-earn) with measurable lead quality impact Entry path:
  1. LinkedIn jobs / Peak XV portfolio
  2. Founders: Priyanshu Jain, Arjun Harish, Tarithmay Mandal
  3. Angle: non-metro user behavior + habit formation in quick commerce Outreach draft:

Hi Priyanshu — BazaarNow’s Tier 2/3 focus resonates. Before PM, I led field sales across 20+ Indian geographies; at HealthPlix I turned that ground insight into product prioritization. I’d love to discuss how you’re building habit-led commerce differently from metro-first models.

Risk flags: Early-stage (launched Jan 2026); intense quick-commerce competition.

5. MyGate

Funding: ~$23.6M (₹225 Cr; primary + secondary) — 10 Jun 2026
Source: https://inc42.com/buzz/mygate-secures-%E2%82%B9225-cr-to-fuel-footprint-expansion/
What they do:

  • Gated-community OS: security, payments, household services; 27,000+ societies, 5.7M homes
  • Revenue mix ~70% ads, ~25% core software; FY26 revenue ₹232 Cr (+34% YoY) Why hiring now:
  • Scaling toward 10M homes; Middle East pilot expansion
  • Product investments in household calendar/payments and platform robustness Role hypothesis: Product Manager, Senior Product Manager (consumer/B2B2C platform) Fit thesis: Consumer + B2B2C platform at scale — your experience balancing doctor-facing SaaS with growth mechanics applies to society-resident engagement and monetization layers. Proof points:
  • Platform scaling to 10K+ doctors with >95% retention
  • Funnel instrumentation and roadmap reprioritization from behavioral data Entry path:
  1. MyGate careers page / LinkedIn
  2. CEO Abhishek Kumar (co-founder)
  3. Angle: platform product as they scale societies + international pilots Outreach draft:

Hi Abhishek — congrats on the Dharana Capital round. MyGate’s path to 10M homes and Middle East pilots is an exciting product scale challenge. I’m a PM (ex-HealthPlix) who’s shipped platform features and growth loops in high-retention B2B2C contexts. Would welcome 15 minutes on your product priorities.

Risk flags: Mature company (~2016 founded); ad-revenue dependence; may have established PM bench.

6. Manam Chocolate

Funding: $9M Series A — 11 Jun 2026
Source: https://economictimes.indiatimes.com/tech/funding/manam-chocolate-raises-9-million-funding-from-omnivore-turner-morrison/articleshow/131650182.cms
What they do:

  • Premium D2C craft chocolate; farm-to-bar with 250+ farmer network in Andhra Pradesh
  • 3 retail stores today; experiential retail expansion planned (Delhi-NCR, target 18 stores in 2 years) Why hiring now:
  • Series A to scale retail footprint, supply chain, and new product categories
  • Vertically integrated model needs strong consumer + ops product Role hypothesis: Product Manager (D2C/retail experience), Senior Product Manager Fit thesis: Consumer-first brand scaling offline + potentially online — your D2C-adjacent work (growth loops, conversion funnels) and psychology background fit experiential retail product. Proof points:
  • Demo-to-activation conversion improvement on 0-to-1 launch at HealthPlix
  • SceneDrop / Next Workout consumer product concepts — research-led product design Entry path:
  1. LinkedIn / Omnivore portfolio job boards
  2. Founder Chaitanya Muppala
  3. Angle: retail experience + supply chain traceability as product differentiators Outreach draft:

Hi Chaitanya — Manam’s farm-to-bar + retail expansion is a compelling consumer product story. I’m a PM with healthtech scale experience and a background in user research (psychology grad). I’d love to explore product opportunities as you grow from 3 to 18 stores.

Risk flags: Retail/D2C ops-heavy; PM roles may be limited vs brand/retail ops.

7. Sarvam AI

Funding: $234M Series B (first close of $300M round; $1.5B valuation) — 15 Jun 2026
Source: https://techcrunch.com/2026/06/15/sarvam-becomes-indias-newest-ai-unicorn-with-234-million-funding-round-led-by-hcltech/
What they do:

  • Full-stack sovereign AI: models, infra, enterprise + consumer deployments (Sarvam Samvaad)
  • Shifting toward self-serve tiers, usage-based pricing for startups/SMBs
  • 2M daily conversational AI interactions; HCLTech strategic partnership Why hiring now:
  • Unicorn-scale expansion: agentic AI, coding, cybersecurity applications
  • Broadening access beyond enterprise-only deployments Role hypothesis: Product Manager, Senior Product Manager (platform/API, SMB self-serve) Fit thesis: Enterprise-to-SMB product expansion mirrors HealthPlix scaling phases. Your investor-facing product storytelling and platform scaling experience relevant — though roles may skew senior given unicorn status. Proof points:
  • Series C investor walk-throughs and platform scaling to 10K+ users
  • 0-to-1 product launches with conversion metrics Entry path:
  1. Sarvam AI careers / LinkedIn
  2. Co-founders Vivek Raghavan, Pratyush Kumar
  3. Angle: SMB self-serve product motion as they democratize access Outreach draft:

Hi — congrats on Sarvam’s unicorn milestone. I’m a PM (ex-HealthPlix) who helped scale a healthtech platform through Series C and shipped 0-to-1 products with measurable conversion impact. I’m interested in how you’re building self-serve tiers for SMBs — would welcome a brief conversation.

Risk flags: Very senior hiring bar at unicorn; AI/infra-heavy; may prefer deep ML product background.

8. Zumutor Biologics

Funding: $7.3M Pre-Series B — 15 Jun 2026
Source: https://inc42.com/buzz/zumutor-biologics-secures-7-3-mn-to-advance-clinical-trials-for-cancer-therapy/
What they do:

  • Immuno-oncology biotech; NK cell checkpoint inhibitor (ZM008) in Phase 1/2 trials
  • Bengaluru-based; Accel, Bharat Innovation Fund, Premji Invest backers Why hiring now:
  • Funding to complete US FDA Phase 1, expand Phase 1B/2 globally including India Role hypothesis: Product Manager (clinical data platforms — if any), Program/Platform roles more likely than classic PM Fit thesis: Healthtech adjacency but biotech/clinical — weaker direct PM fit unless they build clinician/patient-facing digital tools around trials. Proof points:
  • HealthPlix clinical workflow understanding
  • Stakeholder management across eng, clinical, and commercial teams Entry path:
  1. LinkedIn / Accel portfolio
  2. Leadership via company website
  3. Angle: only if digital/clinical ops product roles emerge Outreach draft:

Hi — I saw Zumutor’s Pre-Series B news. I’m a healthtech PM (ex-HealthPlix) with experience in clinician-facing SaaS. If you’re building digital tools around trial ops or patient access, I’d welcome a conversation.

Risk flags: Biotech R&D focus; PM roles uncommon; Pre-Series B stage.

9. Rivvun AI

Funding: $7.55M Seed — 10 Jun 2026
Source: https://economictimes.indiatimes.com/tech/funding/rivvun-ai-raises-7-55-million-led-by-sitara-capital-3one4-capital/articleshow/131636944.cms
What they do:

  • Autonomous AI execution layer for enterprise spend/revenue recovery (Fortune 1000)
  • HQ Seattle; engineering in Pune; founders ex-Icertis Why hiring now:
  • Seed to expand GTM, product/R&D, and customer deployment teams in Pune Role hypothesis: Product Manager (enterprise AI agents), Senior Product Manager Fit thesis: B2B SaaS with India engineering hub — Pune-based PM plausible. Enterprise workflow product + data-driven prioritization aligns with your SQL/analytics strengths, though domain is procurement/finance not healthtech. Proof points:
  • Cross-functional shipping (100+ fixes, eng/design/QA/CS) at HealthPlix
  • B2B SaaS stakeholder management Entry path:
  1. Rivvun.ai careers / LinkedIn (Pune)
  2. Founders Anand Veerkar, Niranjan Umarane
  3. Angle: enterprise AI agent product from India eng hub Outreach draft:

Hi Anand — Rivvun’s seed round and Pune engineering hub caught my eye. I’m a B2B SaaS PM (ex-HealthPlix) who ships with eng/design/CS and uses SQL/funnel data for prioritization. Would love to discuss PM opportunities as you scale the execution layer.

Risk flags: Enterprise sales cycle; domain learning curve (procurement/revenue recovery).

10. Uni Seoul

Funding: ~$3.7M (₹35 Cr) Series A — 10 Jun 2026
Source: https://inc42.com/buzz/exclusive-uni-seoul-nets-%E2%82%B935-cr-to-expand-offline-presence-enter-quick-commerce/
What they do:

  • Korean-inspired D2C lifestyle/gifting retail; 15 stores across 6 cities; 1,000+ SKUs
  • Plans: 50+ stores near-term, 500 in 5 years; entering quick commerce Why hiring now:
  • Offline expansion + quick commerce launch + supply chain/private label
  • Riding K-beauty/K-culture wave in India Role hypothesis: Product Manager (retail tech / e-commerce), Senior Product Manager Fit thesis: Consumer retail + omnichannel (offline + quick commerce) — growth and conversion problems similar to consumer product scaling; psychology + research background helps for lifestyle brand UX. Proof points:
  • Growth loop design and acquisition optimization at HealthPlix
  • Consumer product concepts (SceneDrop, Next Workout) with user research Entry path:
  1. LinkedIn jobs
  2. Co-founders Gaurav Karmani, Mohit Khurana
  3. Angle: omnichannel retail product as they enter quick commerce Outreach draft:

Hi Gaurav — Uni Seoul’s offline-to-quick-commerce push is timely given K-culture demand. I’m a consumer-focused PM (ex-HealthPlix) with research + growth experience. I’d welcome a chat about product as you scale toward 50+ stores.

Risk flags: Retail-first; PM may sit under ops/e-commerce lead.

Canada (6 companies)

Note: Jun 9–15 had fewer Canadian seed/Series A/B announcements than usual, and most listed roles require Canadian work eligibility. Remote-from-India verdicts are stated explicitly per company. Where marked Plausible via EOR, no public India PM listing was found — treat as low-probability outreach.

1. Scispot

Funding: $8M USD Series A — 11 Jun 2026
Source: https://www.scispot.com/blog/scispot-series-a-funding
What they do:

  • AI-native lab operating system for life sciences (LIMS/ELN/QMS automation)
  • 125+ labs; Kitchener-Waterloo HQ; YC S21; customers mostly in US Why hiring now:
  • Series A to scale product, engineering, AI, implementation, customer success
  • Forward-deployed model (Palantir-like) — hiring AI engineers and scientists
  • Posted: Senior AI Product Designer/Manager on Y Combinator Work at a Startup Role hypothesis: Senior AI Product Designer/Manager (hybrid PM/design) Remote-from-India: No public India hiring. YC listing shows Remote (ON, CA) — Ontario, Canada only. Cross-border PM from India not verified; EOR-from-India is plausible but unconfirmed for a virtual-first company with US customers. Fit thesis: Strongest Canada healthtech/life-sciences SaaS fit for you — clinician/researcher-facing workflows, AI product, scaling post-Series A. HealthPlix parallel: complex B2B workflow software with retention and onboarding challenges. Proof points:
  • Healthtech SaaS at scale; clinician-facing product ownership
  • SQL/funnel analysis + cross-functional shipping Entry path:
  1. https://www.scispot.com/careers and https://www.ycombinator.com/companies/scispot-io/jobs
  2. Co-founder & CPO Satya Singh (engineer-turned-PM; Expedia/Hotels.com background)
  3. Angle: health-adjacent workflow SaaS PM with India healthtech scale experience Outreach draft:

Hi Satya — congrats on Scispot’s Series A. I’m a PM with 6 years in Indian healthtech (HealthPlix, Series C) — clinician-facing SaaS, funnel analytics, 0-to-1 launches. I saw the Senior AI Product Designer/Manager role. Even though it’s listed ON-remote, I wanted to reach out in case you’re open to India-based PM talent for your global customer base.

Risk flags: Ontario-only remote listing; life-sciences domain learning curve; hybrid PM/design role may expect React prototyping.

2. Lexful

Funding: $7M USD Seed — 11 Jun 2026
Source: https://cfotech.ca/story/lexful-raises-usd-7-million-seed-round-for-msp-ai-docs/
What they do:

  • AI-native IT documentation / “KnowledgeOps” platform for managed service providers (MSPs)
  • Ask Lex assistant, MCP server, PSA/RMM integrations; GA planned July 2026 Why hiring now:
  • Seed to double down on AI agents, integrations, international expansion
  • Posted: Senior Product Manager (Remote — Canada; must be eligible to work in Canada) Role hypothesis: Senior Product Manager Remote-from-India: No — job posting explicitly requires Canadian work eligibility. Fit thesis: B2B SaaS PM with AI-native product — good skill match but location blocker for India-based candidate unless you obtain Canadian work authorization. Proof points:
  • B2B SaaS roadmap and cross-functional delivery at HealthPlix
  • AI product interest (SceneDrop, research-led PRDs) Entry path:
  1. https://lexful.ai/careers
  2. CEO Pinar Ormeci
  3. Only viable if you have/plan Canadian work authorization Outreach draft:

(Skip unless you have Canadian work eligibility.)

Risk flags: Hard Canada work-auth requirement; MSP domain niche.

3. Mycroft

Funding: $3.5M USD Seed — Jun 2026 (exact announcement date not pinned; BetaKit reports round closed in June)
Source: https://betakit.com/mycroft-nabs-3-5-million-usd-to-help-other-tech-startups-simplify-security-and-compliance-with-agentic-ai/
What they do:

  • Agentic AI security & compliance platform for B2B SaaS startups (SOC2, device mgmt, cloud security)
  • Toronto-based; founders ex-PartnerStack; 50+ clients; team scaling 15→20 Why hiring now:
  • Seed to expand GTM and product; head of product Jonathan Mendes (PartnerStack co-founder) already in seat Role hypothesis: Product Manager (future hire — no PM posting found; 1× Head of Product in place) Remote-from-India: Unverified. Toronto-centric team (64% Canada on LinkedIn). Cross-border PM from India not plausible near-term unless they expand distributed hiring. Fit thesis: B2B SaaS for startups — your HealthPlix B2B experience transfers, but security/compliance domain is new and Canada-only hiring likely. Proof points:
  • B2B SaaS shipping with eng/design; trust/compliance adjacent (healthtech regulatory context) Entry path:
  1. Monitor mycroft.io / LinkedIn
  2. CEO Mike Kim or Head of Product Jonathan Mendes
  3. Low-priority unless remote policy changes Outreach draft:

Hi Mike — congrats on Mycroft’s seed round. I’m a B2B SaaS PM (ex-HealthPlix). I know you’re Toronto-based; flagging interest in case you expand remote product hiring as you scale the agentic security platform.

Risk flags: No PM opening; security domain; Canada-focused team.

4. NS/TX Industries (NEW/SCHOOL FOODS)

Funding: $10.5M USD Series A — 10 Jun 2026
Source: https://www.thecanadianpressnews.ca/businesswire_press_releases/ns-tx-industries-secures-10-5m-in-funding-to-scale-alt-protein-manufacturing-platform/article_b904df5b-1b35-5e88-a02c-fdbb5cadf101.html
What they do:

  • Toronto food manufacturing platform for alt-protein whole cuts (NEW/SCHOOL FOODS brand)
  • Vertically integrated facility; tuneable scaffolding technology for co-manufacturing Why hiring now:
  • Series A to scale V2 assembly line and production capacity Role hypothesis: Unlikely PM — ops/manufacturing/R&D roles dominate Remote-from-India: No — physical manufacturing in downtown Toronto. Fit thesis: Weak PM fit (hardware/manufacturing vs your software/consumer healthtech profile). Proof points: N/A for this domain Entry path: Monitor only if they build consumer digital products Outreach draft: (Skip — poor fit) Risk flags: Not a software PM opportunity; on-site manufacturing.

5. Picketa Systems

Funding: $2.1M Seed — 15 Jun 2026
Source: https://betakit.com/picketa-raises-2-1-million-to-help-farmers-make-the-most-of-their-fertilizer/
What they do:

  • AgTech: LENS real-time plant tissue analysis + Fieldbook platform for farmers/ag retailers
  • Fredericton, NB; expanding across Midwest US and Western Canada Why hiring now:
  • Seed to scale LENS manufacturing (hundreds/year) and hire ~5 sales/support staff Role hypothesis: Product Manager (Fieldbook web/mobile) — possible but not advertised Remote-from-India: No — field hardware + North American ag market focus; no India remote evidence. Fit thesis: Some B2B platform experience overlap (Fieldbook app), but ag domain and field-sales motion are far from your core. Proof points:
  • Funnel/analytics skills could apply to farmer-facing app Entry path:
  1. picketa.com / LinkedIn
  2. CEO (check BetaKit: Hébert-Couturier) Outreach draft: (Low priority — domain/location mismatch) Risk flags: Hardware + field ops; Canada/US only; hiring sales/support not PM.

6. NS/TX alternative — Pricepoint (borderline on date)

Skipped from main ranking: Pricepoint announced $6.6M CAD Seed on ~5 Jun 2026 — outside the Jun 9–15 window. Listed here because it’s a strong SaaS PM comp if you extend search:

Funding: $6.6M CAD Seed — ~5 Jun 2026
Source: https://betakit.com/pricepoint-closes-6-6-million-cad-seed-round-for-ai-hospitality-platform/
Remote-from-India: Unverified — Montreal team doubling to ~70; global hotel customers but no India remote listing found.

Skipped / watchlist

CompanyFundingWhy skipped
FirstClub$55M Series B (3–4 Jun)Announced before Jun 9 window
TrueFan AI$10M Series A (4 Jun)Outside window; enterprise video AI — moderate fit
Propsoch$2M Seed (3 Jun; some reports 10 Jun)Borderline date; proptech — moderate fit
Immuneel Therapeutics$10.5M Series B (8 Jun)In window but biotech/clinical — weak PM fit
Ethereal Machines$28.5M Series B (11 Jun)Deep-tech hardware — poor PM fit
Exponent Energy$21M Series B2 (11 Jun)EV infra — poor fit
Innefu Labs$30M Series B (12 Jun)Defence/cyber — poor fit
Pramaana Labs$27M Seed (17 Jun)After Jun 15 window
June Health$2.4M CAD pre-seed (18 Jun)After window; pre-seed stage excluded; Canada-only
KOHO / Nesto / BeaconSeries D+ / C+Wrong stage (beyond Series B)
Lexful$7M SeedStrong PM role but Canada work auth required
TestHive$15M Series A (reported)Could not verify company/funding with primary source — likely unreliable

Week stats

  • India: 23 deals / ~$244M reported for Jun 8–13 per secondary roundups; 10 companies above meet stage ($1M+), source, and fit filters for Jun 9–15.
  • Canada: Sparse week for seed/Series A/B; none of the verified announcements clearly offer remote PM from India. Scispot is the best healthtech-adjacent bet with an active PM-adjacent role (Ontario-remote only).